Molly Klein

1.8k total citations
26 papers, 570 citations indexed

About

Molly Klein is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Molly Klein has authored 26 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Oncology and 6 papers in Obstetrics and Gynecology. Recurrent topics in Molly Klein's work include Endometrial and Cervical Cancer Treatments (5 papers), Breast Cancer Treatment Studies (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Molly Klein is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Breast Cancer Treatment Studies (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Molly Klein collaborates with scholars based in United States, Canada and Germany. Molly Klein's co-authors include Yongli Shuai, Rohit Bhargava, David J. Dabbs, Mahmoud A. Khalifa, Shannon L. Puhalla, Rachel C. Jankowitz, Adam Brufsky, Syed K. Mohsin, Raymond R. Tubbs and Melissa A. Geller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Molly Klein

20 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Klein United States 10 279 251 187 113 83 26 570
Juan Manuel Rosa-Rosa Spain 14 212 0.8× 167 0.7× 239 1.3× 149 1.3× 16 0.2× 24 552
Bangxing Huang China 13 146 0.5× 170 0.7× 206 1.1× 69 0.6× 19 0.2× 23 462
Marta Bellone Italy 11 45 0.2× 243 1.0× 147 0.8× 76 0.7× 76 0.9× 18 446
C. Diana Jordan United States 10 111 0.4× 81 0.3× 252 1.3× 55 0.5× 84 1.0× 13 567
Yen Y. Tan Austria 13 333 1.2× 158 0.6× 140 0.7× 40 0.4× 32 0.4× 35 807
Ahmed El‐Balat Germany 10 74 0.3× 208 0.8× 118 0.6× 166 1.5× 14 0.2× 34 426
Jolijn W. Groeneweg Netherlands 10 71 0.3× 98 0.4× 162 0.9× 123 1.1× 20 0.2× 22 311
Ann‐Kathrin Bittner Germany 17 268 1.0× 291 1.2× 224 1.2× 42 0.4× 265 3.2× 39 790
Hisamitsu Takaya Japan 11 74 0.3× 167 0.7× 130 0.7× 261 2.3× 22 0.3× 28 489
Billie‐Jo Kerns United States 7 98 0.4× 126 0.5× 109 0.6× 110 1.0× 46 0.6× 8 347

Countries citing papers authored by Molly Klein

Since Specialization
Citations

This map shows the geographic impact of Molly Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Klein more than expected).

Fields of papers citing papers by Molly Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Klein. The network helps show where Molly Klein may publish in the future.

Co-authorship network of co-authors of Molly Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Klein. A scholar is included among the top collaborators of Molly Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Klein. Molly Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Molly, et al.. (2024). Implementation of endometrial cancer molecular subtyping into a hybrid community-academic practice. American Journal of Clinical Pathology. 162(1). 75–85.
2.
Khalifa, Mahmoud A., Liam Chen, Paari Murugan, et al.. (2023). Immunohistochemistry and immunofluorescence utilization audit by subspecialty in an academic setting: A step toward stewardship. Annals of Diagnostic Pathology. 67. 152214–152214.
3.
4.
Sahoo, Sunati, Gregor Krings, Yunn‐Yi Chen, et al.. (2022). Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Archives of Pathology & Laboratory Medicine. 147(5). 591–603. 5 indexed citations
5.
Siegel, Lianne, et al.. (2022). Histopathologic Features of Breast Tissue From Transgender Men and Their Associations With Androgen Therapy. American Journal of Clinical Pathology. 159(1). 43–52. 3 indexed citations
6.
Beckwith, Heather, et al.. (2021). Synchronous breast carcinoma and peritoneal mesothelioma. The Breast Journal. 27(6). 550–552. 2 indexed citations
7.
Erickson, Britt, Shari Damast, Adriana Blakaj, et al.. (2020). Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study. Gynecologic Oncology. 159(1). 17–22. 63 indexed citations
8.
Venters, Sara J., Denise M. Wolf, Lamorna Brown Swigart, et al.. (2020). Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial. Cancer Research. 80(4_Supplement). P6–10. 1 indexed citations
9.
Erickson, Britt, Molly Klein, Maryam Shahi, et al.. (2020). Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort.. Journal of Clinical Oncology. 38(15_suppl). 6084–6084. 1 indexed citations
10.
Khalifa, Mahmoud A., et al.. (2019). Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging. Seminars in Ultrasound CT and MRI. 40(4). 358–363. 13 indexed citations
11.
Lou, Emil, Rachel I. Vogel, Molly Klein, et al.. (2019). Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian Cancer. JAMA Oncology. 5(8). 1222–1222. 26 indexed citations
12.
Altman, Ariella M., B. Lamar Johnson, Schelomo Marmor, et al.. (2019). Intraoperative inking is superior to suture marking for specimen orientation in breast cancer. The Breast Journal. 26(4). 661–667. 4 indexed citations
13.
Cartwright, David, et al.. (2019). A Case of Tumor of Follicular Infundibulum Involving the Vulva. SHILAP Revista de lepidopterología. 2019. 1–3.
14.
Khalifa, Mahmoud A., et al.. (2018). Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals. International Journal of Gynecological Pathology. 38(6). 520–527. 43 indexed citations
15.
Winterhoff, Boris, Amit Mitra, Attila Sebe, et al.. (2017). Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells. Gynecologic Oncology. 144(3). 598–606. 77 indexed citations
16.
Salama, Sherine, Rachel I. Vogel, Molly Klein, et al.. (2016). Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed. American Journal of Clinical Pathology. 147(3). 322–326. 6 indexed citations
17.
Dutra, Inês, Houssam Nassif, Yirong Wu, et al.. (2013). Using machine learning to identify benign cases with non-definitive biopsy. PubMed. 222(15th). 283–285.
18.
Klein, Molly, David J. Dabbs, Yongli Shuai, et al.. (2013). Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Modern Pathology. 26(5). 658–664. 141 indexed citations
19.
Dabbs, David J., Molly Klein, Syed K. Mohsin, et al.. (2011). High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study. Journal of Clinical Oncology. 29(32). 4279–4285. 115 indexed citations
20.
Klein, Molly, et al.. (2001). Fertility Treatment in the Forty and Older Woman. Journal of Assisted Reproduction and Genetics. 18(12). 638–643. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Manuel Rosa-Rosa Breakdown of academic impact, for papers by Bangxing Huang Breakdown of academic impact, for papers by Marta Bellone Breakdown of academic impact, for papers by C. Diana Jordan Breakdown of academic impact, for papers by Yen Y. Tan Breakdown of academic impact, for papers by Ahmed El‐Balat Breakdown of academic impact, for papers by Jolijn W. Groeneweg Breakdown of academic impact, for papers by Ann‐Kathrin Bittner Breakdown of academic impact, for papers by Hisamitsu Takaya Breakdown of academic impact, for papers by Billie‐Jo Kerns
Rankless by CCL
2026